| 54 |
Titel |
TI |
[DE] Estergruppen enthaltende Iodoniumsalze und ihre Verwendung zur Strahlenhärtung kationisch härtender Massen
[EN] Iodonium salts containing ester groups as well as their use for radiation hardening of cationic hardable masses
[FR] Sels iodoniques contenant des groupes esters ainsi que leur utilisation pour le durcissement par rayonement des masses durcissables cationiques |
| 71/73 |
Anmelder/Inhaber |
PA |
GOLDSCHMIDT AG TH, DE
|
| 72 |
Erfinder |
IN |
OESTREICH SASCHA DR, DE
|
| 22/96 |
Anmeldedatum |
AD |
26.02.2000 |
| 21 |
Anmeldenummer |
AN |
00104024 |
|
Anmeldeland |
AC |
EP |
|
Veröffentlichungsdatum |
PUB |
13.09.2000 |
33
31
32 |
Priorität |
PRC
PRN
PRD |
DE
19910780
19990311
|
| 51 |
IPC-Hauptklasse |
ICM |
C07C 69/62
|
| 51 |
IPC-Nebenklasse |
ICS |
C08F 2/50
|
|
IPC-Zusatzklasse |
ICA |
|
|
IPC-Indexklasse |
ICI |
|
|
Gemeinsame Patentklassifikation |
CPC |
C07C 69/65
C08F 2/50
G03F 7/0045
G03F 7/029
|
|
MCD-Hauptklasse |
MCM |
C07C 69/712
(2006.01)
|
|
MCD-Nebenklasse |
MCS |
C07C 69/65
(2006.01)
C08F 2/50
(2006.01)
G03F 7/004
(2006.01)
G03F 7/029
(2006.01)
|
|
MCD-Zusatzklasse |
MCA |
|
| 57 |
Zusammenfassung |
AB |
[DE] Die Erfindung betrifft Estergruppen enthaltende Iodoniumsalze mit verringerter Kristallisationsneigung sowie deren Verwendung zur Strahlenhärtung kationisch härtender Massen.
[EN] Ester group containing iodonium salts having decreased tendency to crystallization are new. New iodonium salts having decreased tendency to crystallization have the formula (IV): (R<1>-I-R<2>)<+> X<-> (IV) I = iodine, X<-> = an anion of a metal salt complex or a strong acid, R<1> = a group of formula (A), C = a univalent 6-14C aromatic hydrocarbon, or a univalent 5-15 aromatic hydrocarbon with 5-15 ring atoms per residue and containing at least one oxygen or sulfur atom, a = 1,2, or 3, b = 0, 1 or 2, D, E, and F = substituents, where the D is a residue of formula (B), x = 0 or 1, y = 0 or 1, R<3> = linear or optionally branched 1-40C hydrocarbon, which can be optionally interrupted by at least one oxygen and/or sulfur atom and/or a carboxyl group, R<4> = linear, branched and/or cyclic alkyl, aryl, haloalkyl, haloaryl and/or 1-40C alkoxy, E = a residue of formula -O-R<5>, F = a residue of formula -R<6>, R<2> = a residue of formula (G), R<5>, R<6> = 1-18C hydrocarbon, optionally interrupted by at least one oxygen atom, d, e = 0, 1 or 2. |
| 56 |
Entgegengehaltene Patentdokumente/Zitate,
in Recherche ermittelt |
CT |
US000003862333A
US000005079378A
WO001993013110A1
WO001999048945A1
|
| 56 |
Entgegengehaltene Patentdokumente/Zitate,
vom Anmelder genannt |
CT |
|
| 56 |
Entgegengehaltene Nichtpatentliteratur/Zitate,
in Recherche ermittelt |
CTNP |
CHEMICAL ABSTRACTS, vol. 108, no. 5, 1 February 1988, Columbus, Ohio, US; abstract no. 38334, LEESON, PAUL D. ET AL: "Thyroid hormone analogs. Synthesis of 3'-substituted 3,5-diiodo-L-thyronines and quantitative structure-activity studies of in vitro and in vivo thyromimetic activities in rat liver and heart" XP002142083 0;
J. MED. CHEM. (1988), 31(1), 37-54 0
|
| 56 |
Entgegengehaltene Nichtpatentliteratur/Zitate,
vom Anmelder genannt |
CTNP |
|
|
Zitierende Dokumente |
|
Dokumente ermitteln
|
|
Sequenzprotokoll |
|
|
|
Prüfstoff-IPC |
ICP |
C07C 69/62
C08F 2/50
|
